I find it interesting that Dr. Reddy's makes Brila
Post# of 72437
![](/assets/46931549/no_avatar_available_thumb.jpg)
In 2015, Dr. Reddy's Laboratories bought the established brands of Belgian drugmaker UCB SA in South Asia for 8 billion rupees ($128.38 million).[11] Dr. Reddy's Laboratories also signed a licensing pact with XenoPort for their experimental treatment to treat plaque psoriasis. As per the agreement, Dr. Reddy’s will be granted exclusive US rights to develop and commercialize XP23829 for all indications for an upfront payment of $47.5 million. [12]
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)